Toggle Main Menu Toggle Search

Open Access padlockePrints

A first-in-human dose-escalation study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of oral 2-hydroxyoleic acid (2-OHOA) in adult patients (pt) with advanced solid tumors including grade III/IV glioblastoma multiforme (GBM).

Lookup NU author(s): Dr Yvette DrewORCiD, Dr Alastair GreystokeORCiD, Professor Ruth Plummer


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Roda D, Drew Y, Azaro A, Smith AD, Greystoke A, Sicart E, Escriba PV, Busquets X, Llado V, Tur V, Klumper E, Ahnert JR, Molife LR, Plummer R

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 2015 American Society of Clinical Oncology Annual Meeting

Year of Conference: 2015

Print publication date: 18/05/2015

Acceptance date: 01/01/1900

ISSN: 0732-183X

Publisher: American Society of Clinical Oncology


Series Title: Journal of Clinical Oncology